Bloomberg Law (12/20, Phengsitthy , Subscription Publication) reported, “The US government is going after drugmakers such as Bristol Myers Squibb Co., Johnson & Johnson, and Merck & Co. to pay rebates to Medicare if they raise the price of some of their drugs faster than inflation beginning in January.” A number of “Medicare enrollees will pay a lower coinsurance rate for 64 drugs treating cancer, osteoporosis, and substance use disorder between Jan. 1 and March 31, 2025, the US Department of Health and Human Services said Friday.” According to HHS, “over 853,000 people with Medicare use these drugs annually.” Beneficiaries who take these drugs “in the first quarter of 2025 may save between $1 and $10,818 per day, according to the agency.”
Related Links:
— “Medicare Imposes Savings on 64 Drugs Exceeding Inflation Rate,” Nyah Phengsitthy, Bloomberg Law, December 20, 2024